May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Angiographic Patterns and Locations of Choroidal Neovascularization (CNV) in Patients With Exudative Age–Related Macular Degeneration (ARMD): A Retrospective Review of Fluorescein Angiograms at the Kresge Eye Insitute Over a Three–Year Period
Author Affiliations & Notes
  • S. Mukerjee
    Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • A. Tewari
    Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • O. Plous
    Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • J.E. Puklin
    Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • Footnotes
    Commercial Relationships  S. Mukerjee, None; A. Tewari, None; O. Plous, None; J.E. Puklin, None.
  • Footnotes
    Support  Alcon Laboratories; RPB
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 228. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Mukerjee, A. Tewari, O. Plous, J.E. Puklin; Angiographic Patterns and Locations of Choroidal Neovascularization (CNV) in Patients With Exudative Age–Related Macular Degeneration (ARMD): A Retrospective Review of Fluorescein Angiograms at the Kresge Eye Insitute Over a Three–Year Period . Invest. Ophthalmol. Vis. Sci. 2005;46(13):228.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The purpose of this study is to identify new, untreated CNV's in patients with ARMD presenting to a large urban eye center and to determine the type and location of these CNV's as defined by the Macular Photocoagulation Study (MPS) and the Treatment of Age–Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Methods: Fluorescein angiographic patterns of exudative ARMD were categorized by two schemes: the MPS and the TAP. CNV's were categorized by location (subfoveal, juxtafoveal, extrafoveal), type (occult or classic), and subtype (classic: purely, predominantly, minimally; occult: fibrovascular pigment epithelial detachment (PED), late phase leakage of undetermined source). The archived angiogram database was reviewed from December 2001 to October 2004 for all patients with a presumptive diagnosis of ARMD. The first fluorescein angiogram of each eye was selected for analysis. Seven–hundred and forty patients were initially identified in the database with ARMD. Patients' eyes were excluded if the angiogram demonstrated non–exudative ARMD, poor quality photography, or scarred or previously treated lesions. One–hundred and thirty–four eyes met the criteria of new choroidal neovascular membranes associated with ARMD. Results: According to the MPS classification, 67/134 (50.0%) of the lesions were subfoveal, 41/134 (30.6%) were juxtafoveal, and 26/134 (19.4%) were extrafoveal, 104/134 (77.61%) of membranes being classic and 30/134 (22.39%) being occult. Of the occult lesions, 20/134 (14.93%) were fibrovascular PEDs and 10/134 (7.46%) were late phase leakage of undetermined source. As defined by the TAP classification, the classic CNV subtypes were distributed as follows: 84/134 (62.69%) purely classic, 11/134 (8.21%) predominantly classic, and 9/134 (6.72%) minimally classic. Conclusions: The classic type of CNV is the principal type of membrane in exudative ARMD, of which the most prevalent subtype is purely classic followed in frequency by the predominantly and minimally classic subtypes. Two–thirds of the occult lesions were fibrovascular PEDs, with one–third being the late phase leakage of undetermined source subtype. CNVs tend to be focused on the fovea, as the primary lesion location is subfoveal, followed in prevalence by juxtafoveal and extrafoveal lesions.

Keywords: age-related macular degeneration • choroid: neovascularization • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×